4-(Benzyloxy)benzhydrazide - CAS 128958-65-6
Catalog: |
BB006955 |
Product Name: |
4-(Benzyloxy)benzhydrazide |
CAS: |
128958-65-6 |
Synonyms: |
4-phenylmethoxybenzohydrazide; 4-phenylmethoxybenzohydrazide |
IUPAC Name: | 4-phenylmethoxybenzohydrazide |
Description: | 4-(Benzyloxy)benzhydrazide (CAS# 128958-65-6) is a useful research chemical. |
Molecular Weight: | 242.27 |
Molecular Formula: | C14H14N2O2 |
Canonical SMILES: | C1=CC=C(C=C1)COC2=CC=C(C=C2)C(=O)NN |
InChI: | InChI=1S/C14H14N2O2/c15-16-14(17)12-6-8-13(9-7-12)18-10-11-4-2-1-3-5-11/h1-9H,10,15H2,(H,16,17) |
InChI Key: | LZMCSSDFZRJZIS-UHFFFAOYSA-N |
Density: | 1.201 g/cm3 |
Storage: | Keep in dark place, Inert atmosphere, Room temperature |
MDL: | MFCD00564772 |
LogP: | 2.96030 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-2020164024-A1 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorders | 20181127 |
WO-2020110009-A1 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorders | 20181127 |
EP-3887365-A1 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorders | 20181127 |
KR-20210096154-A | Cyclic tetrameric compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders | 20181127 |
US-11026993-B2 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders | 20181127 |
PMID | Publication Date | Title | Journal |
20452224 | 20100601 | New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site | Bioorganic & medicinal chemistry |
Complexity: | 257 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 242.105527694 |
Formal Charge: | 0 |
Heavy Atom Count: | 18 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 242.105527694 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 64.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS